476 related articles for article (PubMed ID: 22018950)
1. Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis.
Wang LG; Gu J
Cancer Epidemiol; 2012 Feb; 36(1):e61-7. PubMed ID: 22018950
[TBL] [Abstract][Full Text] [Related]
2. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.
Toiyama Y; Hur K; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
Ann Surg; 2014 Apr; 259(4):735-43. PubMed ID: 23982750
[TBL] [Abstract][Full Text] [Related]
3. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer.
Hur K; Toiyama Y; Okugawa Y; Ide S; Imaoka H; Boland CR; Goel A
Gut; 2017 Apr; 66(4):654-665. PubMed ID: 26701878
[TBL] [Abstract][Full Text] [Related]
5. Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia.
Yamada A; Horimatsu T; Okugawa Y; Nishida N; Honjo H; Ida H; Kou T; Kusaka T; Sasaki Y; Yagi M; Higurashi T; Yukawa N; Amanuma Y; Kikuchi O; Muto M; Ueno Y; Nakajima A; Chiba T; Boland CR; Goel A
Clin Cancer Res; 2015 Sep; 21(18):4234-42. PubMed ID: 26038573
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of microRNA-29a for colorectal cancer: a meta-analysis.
Zhi ML; Liu ZJ; Yi XY; Zhang LJ; Bao YX
Genet Mol Res; 2015 Dec; 14(4):18018-25. PubMed ID: 26782449
[TBL] [Abstract][Full Text] [Related]
7. Serum miR-92a-1 is a novel diagnostic biomarker for colorectal cancer.
Shi Y; Liu Z
J Cell Mol Med; 2020 Aug; 24(15):8363-8367. PubMed ID: 32562465
[TBL] [Abstract][Full Text] [Related]
8. Identification and evaluation of plasma microRNAs for early detection of colorectal cancer.
Luo X; Stock C; Burwinkel B; Brenner H
PLoS One; 2013; 8(5):e62880. PubMed ID: 23690963
[TBL] [Abstract][Full Text] [Related]
9. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.
Huang Z; Huang D; Ni S; Peng Z; Sheng W; Du X
Int J Cancer; 2010 Jul; 127(1):118-26. PubMed ID: 19876917
[TBL] [Abstract][Full Text] [Related]
10. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.
Miyoshi J; Toden S; Yoshida K; Toiyama Y; Alberts SR; Kusunoki M; Sinicrope FA; Goel A
Sci Rep; 2017 Mar; 7():43393. PubMed ID: 28262692
[TBL] [Abstract][Full Text] [Related]
11. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
[TBL] [Abstract][Full Text] [Related]
12. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
[TBL] [Abstract][Full Text] [Related]
13. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
[TBL] [Abstract][Full Text] [Related]
14. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
15. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
16. Circulating miR-17-3p, miR-29a, miR-92a and miR-135b in serum: Evidence against their usage as biomarkers in colorectal cancer.
Faltejskova P; Bocanek O; Sachlova M; Svoboda M; Kiss I; Vyzula R; Slaby O
Cancer Biomark; 2012; 12(4):199-204. PubMed ID: 23568010
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Serum MicroRNA-21 Gene Expression for Diagnosis and Prognosis of Colorectal Cancer.
Ghareib AF; Mohamed RH; Abd El-Fatah AR; Saadawy SF
J Gastrointest Cancer; 2020 Sep; 51(3):818-823. PubMed ID: 31482406
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of miR-17 is correlated with liver metastasis in colorectal cancer.
Lai H; Zhang J; Zuo H; Liu H; Xu J; Feng Y; Lin Y; Mo X
Medicine (Baltimore); 2020 Feb; 99(9):e19265. PubMed ID: 32118734
[TBL] [Abstract][Full Text] [Related]
19. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
[TBL] [Abstract][Full Text] [Related]
20. microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer.
Zhang Y; He X; Liu Y; Ye Y; Zhang H; He P; Zhang Q; Dong L; Liu Y; Dong J
Oncol Rep; 2012 Mar; 27(3):685-94. PubMed ID: 22134529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]